nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Ethylmorphine—POR—urinary bladder cancer	0.0252	0.42	CrCbGaD
Hydrocodone—Codeine—UGT2B7—urinary bladder cancer	0.0163	0.273	CrCbGaD
Hydrocodone—Morphine—UGT2B7—urinary bladder cancer	0.0132	0.221	CrCbGaD
Hydrocodone—Naloxone—ESR1—urinary bladder cancer	0.00517	0.0863	CrCbGaD
Hydrocodone—Osteoarthritis—Methotrexate—urinary bladder cancer	0.0029	0.00309	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00289	0.00307	CcSEcCtD
Hydrocodone—Menopausal symptoms—Epirubicin—urinary bladder cancer	0.00288	0.00306	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00286	0.00304	CcSEcCtD
Hydrocodone—Myalgia—Fluorouracil—urinary bladder cancer	0.00286	0.00304	CcSEcCtD
Hydrocodone—Fatigue—Thiotepa—urinary bladder cancer	0.00286	0.00304	CcSEcCtD
Hydrocodone—Constipation—Thiotepa—urinary bladder cancer	0.00283	0.00301	CcSEcCtD
Hydrocodone—Back pain—Etoposide—urinary bladder cancer	0.00282	0.003	CcSEcCtD
Hydrocodone—Muscle spasms—Etoposide—urinary bladder cancer	0.0028	0.00298	CcSEcCtD
Hydrocodone—Lethargy—Epirubicin—urinary bladder cancer	0.00277	0.00295	CcSEcCtD
Hydrocodone—Convulsion—Cisplatin—urinary bladder cancer	0.00276	0.00293	CcSEcCtD
Hydrocodone—Mood swings—Methotrexate—urinary bladder cancer	0.00275	0.00292	CcSEcCtD
Hydrocodone—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00273	0.00291	CcSEcCtD
Hydrocodone—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00273	0.0029	CcSEcCtD
Hydrocodone—Osteoarthritis—Epirubicin—urinary bladder cancer	0.00271	0.00289	CcSEcCtD
Hydrocodone—Pain in extremity—Epirubicin—urinary bladder cancer	0.00271	0.00289	CcSEcCtD
Hydrocodone—Myalgia—Cisplatin—urinary bladder cancer	0.00271	0.00288	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00271	0.00288	CcSEcCtD
Hydrocodone—Skin disorder—Gemcitabine—urinary bladder cancer	0.00271	0.00288	CcSEcCtD
Hydrocodone—Anxiety—Cisplatin—urinary bladder cancer	0.0027	0.00287	CcSEcCtD
Hydrocodone—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00269	0.00287	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00269	0.00286	CcSEcCtD
Hydrocodone—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00269	0.00286	CcSEcCtD
Hydrocodone—Hot flush—Doxorubicin—urinary bladder cancer	0.00268	0.00286	CcSEcCtD
Hydrocodone—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00268	0.00285	CcSEcCtD
Hydrocodone—Affect lability—Epirubicin—urinary bladder cancer	0.00267	0.00284	CcSEcCtD
Hydrocodone—Migraine—Epirubicin—urinary bladder cancer	0.00267	0.00284	CcSEcCtD
Hydrocodone—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.00266	0.00283	CcSEcCtD
Hydrocodone—Abdominal pain—Thiotepa—urinary bladder cancer	0.00262	0.00279	CcSEcCtD
Hydrocodone—Body temperature increased—Thiotepa—urinary bladder cancer	0.00262	0.00279	CcSEcCtD
Hydrocodone—Hypotension—Gemcitabine—urinary bladder cancer	0.0026	0.00277	CcSEcCtD
Hydrocodone—Mood swings—Epirubicin—urinary bladder cancer	0.00257	0.00273	CcSEcCtD
Hydrocodone—Lethargy—Doxorubicin—urinary bladder cancer	0.00256	0.00273	CcSEcCtD
Hydrocodone—Hypotension—Fluorouracil—urinary bladder cancer	0.00256	0.00272	CcSEcCtD
Hydrocodone—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00255	0.00271	CcSEcCtD
Hydrocodone—Cough—Etoposide—urinary bladder cancer	0.00254	0.00271	CcSEcCtD
Hydrocodone—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00254	0.00271	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00254	0.0027	CcSEcCtD
Hydrocodone—Convulsion—Etoposide—urinary bladder cancer	0.00253	0.00269	CcSEcCtD
Hydrocodone—Dehydration—Epirubicin—urinary bladder cancer	0.00252	0.00268	CcSEcCtD
Hydrocodone—Skin disorder—Cisplatin—urinary bladder cancer	0.00252	0.00268	CcSEcCtD
Hydrocodone—Insomnia—Gemcitabine—urinary bladder cancer	0.00252	0.00268	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.00251	0.00267	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—urinary bladder cancer	0.00251	0.00267	CcSEcCtD
Hydrocodone—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00251	0.00267	CcSEcCtD
Hydrocodone—Paraesthesia—Gemcitabine—urinary bladder cancer	0.0025	0.00266	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.0025	0.00266	CcSEcCtD
Hydrocodone—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00248	0.00264	CcSEcCtD
Hydrocodone—Insomnia—Fluorouracil—urinary bladder cancer	0.00248	0.00264	CcSEcCtD
Hydrocodone—Somnolence—Gemcitabine—urinary bladder cancer	0.00248	0.00264	CcSEcCtD
Hydrocodone—Migraine—Doxorubicin—urinary bladder cancer	0.00247	0.00263	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—urinary bladder cancer	0.00247	0.00263	CcSEcCtD
Hydrocodone—Hypokalaemia—Epirubicin—urinary bladder cancer	0.00247	0.00263	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00247	0.00262	CcSEcCtD
Hydrocodone—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00246	0.00262	CcSEcCtD
Hydrocodone—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00244	0.0026	CcSEcCtD
Hydrocodone—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00244	0.0026	CcSEcCtD
Hydrocodone—Somnolence—Fluorouracil—urinary bladder cancer	0.00244	0.00259	CcSEcCtD
Hydrocodone—Hypotension—Cisplatin—urinary bladder cancer	0.00243	0.00258	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00241	0.00256	CcSEcCtD
Hydrocodone—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.0024	0.00256	CcSEcCtD
Hydrocodone—Fatigue—Gemcitabine—urinary bladder cancer	0.0024	0.00256	CcSEcCtD
Hydrocodone—Constipation—Gemcitabine—urinary bladder cancer	0.00238	0.00254	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—urinary bladder cancer	0.00238	0.00253	CcSEcCtD
Hydrocodone—Asthenia—Thiotepa—urinary bladder cancer	0.00238	0.00253	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00237	0.00252	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00237	0.00252	CcSEcCtD
Hydrocodone—Pruritus—Thiotepa—urinary bladder cancer	0.00234	0.00249	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—urinary bladder cancer	0.00234	0.00248	CcSEcCtD
Hydrocodone—Paraesthesia—Cisplatin—urinary bladder cancer	0.00233	0.00248	CcSEcCtD
Hydrocodone—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00233	0.00248	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00233	0.00248	CcSEcCtD
Hydrocodone—Dyspnoea—Cisplatin—urinary bladder cancer	0.00232	0.00246	CcSEcCtD
Hydrocodone—Skin disorder—Etoposide—urinary bladder cancer	0.00231	0.00246	CcSEcCtD
Hydrocodone—Hyperhidrosis—Etoposide—urinary bladder cancer	0.0023	0.00245	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00229	0.00243	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00224	0.00239	CcSEcCtD
Hydrocodone—Drowsiness—Methotrexate—urinary bladder cancer	0.00223	0.00238	CcSEcCtD
Hydrocodone—Hypotension—Etoposide—urinary bladder cancer	0.00222	0.00237	CcSEcCtD
Hydrocodone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0022	0.00234	CcSEcCtD
Hydrocodone—Dizziness—Thiotepa—urinary bladder cancer	0.00219	0.00233	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00218	0.00232	CcSEcCtD
Hydrocodone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00217	0.0023	CcSEcCtD
Hydrocodone—Paraesthesia—Etoposide—urinary bladder cancer	0.00214	0.00227	CcSEcCtD
Hydrocodone—Dyspnoea—Etoposide—urinary bladder cancer	0.00212	0.00226	CcSEcCtD
Hydrocodone—Somnolence—Etoposide—urinary bladder cancer	0.00212	0.00225	CcSEcCtD
Hydrocodone—Vomiting—Thiotepa—urinary bladder cancer	0.00211	0.00224	CcSEcCtD
Hydrocodone—Drowsiness—Epirubicin—urinary bladder cancer	0.00209	0.00222	CcSEcCtD
Hydrocodone—Rash—Thiotepa—urinary bladder cancer	0.00209	0.00222	CcSEcCtD
Hydrocodone—Dermatitis—Thiotepa—urinary bladder cancer	0.00209	0.00222	CcSEcCtD
Hydrocodone—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00209	0.00222	CcSEcCtD
Hydrocodone—Headache—Thiotepa—urinary bladder cancer	0.00208	0.00221	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00205	0.00219	CcSEcCtD
Hydrocodone—Body temperature increased—Cisplatin—urinary bladder cancer	0.00205	0.00218	CcSEcCtD
Hydrocodone—Fatigue—Etoposide—urinary bladder cancer	0.00205	0.00218	CcSEcCtD
Hydrocodone—Constipation—Etoposide—urinary bladder cancer	0.00203	0.00216	CcSEcCtD
Hydrocodone—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00203	0.00216	CcSEcCtD
Hydrocodone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00202	0.00215	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00202	0.00215	CcSEcCtD
Hydrocodone—Asthenia—Gemcitabine—urinary bladder cancer	0.002	0.00213	CcSEcCtD
Hydrocodone—Pruritus—Gemcitabine—urinary bladder cancer	0.00197	0.0021	CcSEcCtD
Hydrocodone—Nausea—Thiotepa—urinary bladder cancer	0.00197	0.00209	CcSEcCtD
Hydrocodone—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00195	0.00208	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00195	0.00207	CcSEcCtD
Hydrocodone—Pruritus—Fluorouracil—urinary bladder cancer	0.00194	0.00206	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—urinary bladder cancer	0.00194	0.00206	CcSEcCtD
Hydrocodone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00191	0.00204	CcSEcCtD
Hydrocodone—Abdominal pain—Etoposide—urinary bladder cancer	0.00188	0.002	CcSEcCtD
Hydrocodone—Body temperature increased—Etoposide—urinary bladder cancer	0.00188	0.002	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00188	0.002	CcSEcCtD
Hydrocodone—Asthenia—Cisplatin—urinary bladder cancer	0.00186	0.00198	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00185	0.00197	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00185	0.00196	CcSEcCtD
Hydrocodone—Angiopathy—Methotrexate—urinary bladder cancer	0.00182	0.00194	CcSEcCtD
Hydrocodone—Dizziness—Fluorouracil—urinary bladder cancer	0.00181	0.00193	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00181	0.00192	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00181	0.00192	CcSEcCtD
Hydrocodone—Vomiting—Gemcitabine—urinary bladder cancer	0.00177	0.00188	CcSEcCtD
Hydrocodone—Mental disorder—Methotrexate—urinary bladder cancer	0.00176	0.00187	CcSEcCtD
Hydrocodone—Rash—Gemcitabine—urinary bladder cancer	0.00176	0.00187	CcSEcCtD
Hydrocodone—Dermatitis—Gemcitabine—urinary bladder cancer	0.00176	0.00187	CcSEcCtD
Hydrocodone—Hypersensitivity—Etoposide—urinary bladder cancer	0.00175	0.00187	CcSEcCtD
Hydrocodone—Malnutrition—Methotrexate—urinary bladder cancer	0.00175	0.00186	CcSEcCtD
Hydrocodone—Headache—Gemcitabine—urinary bladder cancer	0.00175	0.00186	CcSEcCtD
Hydrocodone—Vomiting—Fluorouracil—urinary bladder cancer	0.00174	0.00185	CcSEcCtD
Hydrocodone—Rash—Fluorouracil—urinary bladder cancer	0.00173	0.00184	CcSEcCtD
Hydrocodone—Dermatitis—Fluorouracil—urinary bladder cancer	0.00173	0.00184	CcSEcCtD
Hydrocodone—Headache—Fluorouracil—urinary bladder cancer	0.00172	0.00183	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00171	0.00182	CcSEcCtD
Hydrocodone—Asthenia—Etoposide—urinary bladder cancer	0.00171	0.00182	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00171	0.00182	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—urinary bladder cancer	0.0017	0.00181	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00169	0.0018	CcSEcCtD
Hydrocodone—Back pain—Methotrexate—urinary bladder cancer	0.00169	0.0018	CcSEcCtD
Hydrocodone—Pruritus—Etoposide—urinary bladder cancer	0.00168	0.00179	CcSEcCtD
Hydrocodone—Nausea—Gemcitabine—urinary bladder cancer	0.00166	0.00176	CcSEcCtD
Hydrocodone—Vomiting—Cisplatin—urinary bladder cancer	0.00165	0.00176	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—urinary bladder cancer	0.00164	0.00175	CcSEcCtD
Hydrocodone—Rash—Cisplatin—urinary bladder cancer	0.00164	0.00174	CcSEcCtD
Hydrocodone—Dermatitis—Cisplatin—urinary bladder cancer	0.00164	0.00174	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—urinary bladder cancer	0.00163	0.00174	CcSEcCtD
Hydrocodone—Nausea—Fluorouracil—urinary bladder cancer	0.00163	0.00173	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—urinary bladder cancer	0.00158	0.00168	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—urinary bladder cancer	0.00158	0.00168	CcSEcCtD
Hydrocodone—Dizziness—Etoposide—urinary bladder cancer	0.00157	0.00167	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—urinary bladder cancer	0.00157	0.00167	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00157	0.00167	CcSEcCtD
Hydrocodone—Nausea—Cisplatin—urinary bladder cancer	0.00154	0.00164	CcSEcCtD
Hydrocodone—Cough—Methotrexate—urinary bladder cancer	0.00152	0.00162	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—urinary bladder cancer	0.00152	0.00162	CcSEcCtD
Hydrocodone—Convulsion—Methotrexate—urinary bladder cancer	0.00151	0.00161	CcSEcCtD
Hydrocodone—Vomiting—Etoposide—urinary bladder cancer	0.00151	0.00161	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—urinary bladder cancer	0.00151	0.00161	CcSEcCtD
Hydrocodone—Rash—Etoposide—urinary bladder cancer	0.0015	0.0016	CcSEcCtD
Hydrocodone—Dermatitis—Etoposide—urinary bladder cancer	0.0015	0.00159	CcSEcCtD
Hydrocodone—Headache—Etoposide—urinary bladder cancer	0.00149	0.00159	CcSEcCtD
Hydrocodone—Myalgia—Methotrexate—urinary bladder cancer	0.00149	0.00158	CcSEcCtD
Hydrocodone—Arthralgia—Methotrexate—urinary bladder cancer	0.00149	0.00158	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00148	0.00157	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—urinary bladder cancer	0.00146	0.00156	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00145	0.00155	CcSEcCtD
Hydrocodone—Cough—Epirubicin—urinary bladder cancer	0.00143	0.00152	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—urinary bladder cancer	0.00142	0.00151	CcSEcCtD
Hydrocodone—Nausea—Etoposide—urinary bladder cancer	0.00141	0.0015	CcSEcCtD
Hydrocodone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.0014	0.00149	CcSEcCtD
Hydrocodone—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.0014	0.00148	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—urinary bladder cancer	0.00139	0.00148	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—urinary bladder cancer	0.00139	0.00148	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—urinary bladder cancer	0.00139	0.00148	CcSEcCtD
Hydrocodone—Skin disorder—Methotrexate—urinary bladder cancer	0.00138	0.00147	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00138	0.00147	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00138	0.00147	CcSEcCtD
Hydrocodone—Dry mouth—Epirubicin—urinary bladder cancer	0.00136	0.00145	CcSEcCtD
Hydrocodone—Hypotension—Methotrexate—urinary bladder cancer	0.00133	0.00142	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—urinary bladder cancer	0.00132	0.0014	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—urinary bladder cancer	0.00131	0.00139	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00131	0.00139	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00131	0.00139	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.0013	0.00138	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—urinary bladder cancer	0.0013	0.00138	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00129	0.00137	CcSEcCtD
Hydrocodone—Insomnia—Methotrexate—urinary bladder cancer	0.00129	0.00137	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—urinary bladder cancer	0.00129	0.00137	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—urinary bladder cancer	0.00129	0.00137	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—urinary bladder cancer	0.00128	0.00136	CcSEcCtD
Hydrocodone—Paraesthesia—Methotrexate—urinary bladder cancer	0.00128	0.00136	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00128	0.00136	CcSEcCtD
Hydrocodone—Dyspnoea—Methotrexate—urinary bladder cancer	0.00127	0.00135	CcSEcCtD
Hydrocodone—Somnolence—Methotrexate—urinary bladder cancer	0.00127	0.00135	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—urinary bladder cancer	0.00126	0.00134	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—urinary bladder cancer	0.00125	0.00133	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00123	0.00131	CcSEcCtD
Hydrocodone—Fatigue—Methotrexate—urinary bladder cancer	0.00123	0.00131	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00122	0.00129	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00121	0.00129	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00121	0.00129	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—urinary bladder cancer	0.00121	0.00128	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—urinary bladder cancer	0.0012	0.00128	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—urinary bladder cancer	0.0012	0.00127	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00119	0.00127	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—urinary bladder cancer	0.00119	0.00127	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—urinary bladder cancer	0.00119	0.00126	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00117	0.00124	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—urinary bladder cancer	0.00115	0.00123	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00115	0.00123	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—urinary bladder cancer	0.00115	0.00122	CcSEcCtD
Hydrocodone—Constipation—Epirubicin—urinary bladder cancer	0.00114	0.00121	CcSEcCtD
Hydrocodone—Abdominal pain—Methotrexate—urinary bladder cancer	0.00113	0.0012	CcSEcCtD
Hydrocodone—Body temperature increased—Methotrexate—urinary bladder cancer	0.00113	0.0012	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00112	0.0012	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—urinary bladder cancer	0.00112	0.00119	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00111	0.00118	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.0011	0.00117	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—urinary bladder cancer	0.0011	0.00117	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00109	0.00116	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00107	0.00113	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—urinary bladder cancer	0.00106	0.00113	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—urinary bladder cancer	0.00106	0.00112	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—urinary bladder cancer	0.00105	0.00112	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—urinary bladder cancer	0.00105	0.00112	CcSEcCtD
Hydrocodone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00105	0.00112	CcSEcCtD
Hydrocodone—Asthenia—Methotrexate—urinary bladder cancer	0.00102	0.00109	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00101	0.00107	CcSEcCtD
Hydrocodone—Pruritus—Methotrexate—urinary bladder cancer	0.00101	0.00107	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000983	0.00105	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000976	0.00104	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000976	0.00104	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—urinary bladder cancer	0.000957	0.00102	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—urinary bladder cancer	0.000944	0.001	CcSEcCtD
Hydrocodone—Dizziness—Methotrexate—urinary bladder cancer	0.000943	0.001	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000909	0.000967	CcSEcCtD
Hydrocodone—Vomiting—Methotrexate—urinary bladder cancer	0.000906	0.000964	CcSEcCtD
Hydrocodone—Rash—Methotrexate—urinary bladder cancer	0.000899	0.000956	CcSEcCtD
Hydrocodone—Dermatitis—Methotrexate—urinary bladder cancer	0.000898	0.000955	CcSEcCtD
Hydrocodone—Headache—Methotrexate—urinary bladder cancer	0.000893	0.00095	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—urinary bladder cancer	0.000886	0.000942	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—urinary bladder cancer	0.000882	0.000938	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—urinary bladder cancer	0.000873	0.000929	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—urinary bladder cancer	0.000848	0.000902	CcSEcCtD
Hydrocodone—Nausea—Methotrexate—urinary bladder cancer	0.000847	0.000901	CcSEcCtD
Hydrocodone—Rash—Epirubicin—urinary bladder cancer	0.000841	0.000895	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—urinary bladder cancer	0.00084	0.000894	CcSEcCtD
Hydrocodone—Headache—Epirubicin—urinary bladder cancer	0.000836	0.000889	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—urinary bladder cancer	0.000816	0.000868	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—urinary bladder cancer	0.000792	0.000843	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—urinary bladder cancer	0.000785	0.000835	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—urinary bladder cancer	0.000778	0.000828	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000777	0.000827	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—urinary bladder cancer	0.000773	0.000823	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—urinary bladder cancer	0.000733	0.00078	CcSEcCtD
